China's IVD market, valued at $16.6 billion in 2023, shows growth potential across various segments, including molecular diagnostics, point-of-care testing, immunoassay, hematology, pathology, microbiology, and clinical biochemicals.
This webinar will provide an overview of China's IVD market, highlighting market opportunities, access requirements, IP considerations, and the latest regulatory updates.
Who should join this webinar?
- Innovative medical equipment/device and IVD manufacturers
- IVD test kits / IVD equipment manufacturers
- Laboratory service providers
- MedTech product Intellectual Property owners and attorneys
- International market access and regulatory managers
- Overseas sales and marketing directors
Agenda & Speakers
-Moderator: Kerry Barnett, Global Healthcare Team Leader, U.S. Commercial Service
-Welcome Remarks, Jade Sims, Commercial Officer, U.S. Embassy Beijing (5')
-IP Protection in China, Juli Schwartz, IP Attaché, United States Patent and Trademark Office, U.S. Consulate General Shanghai (10')
-New Trends and Marketing Strategies in China IVD Market, Karen Dai, Executive
General Secretary of China Association of In-Vitro Diagnostics (10')
-Overview of the IVD Market in China, Edwina Dong, IVD Senior Consultant, IQVIA (15')
-NMPA Regulatory Requirements and Registration Pathway, Grace Fu Palma, Principal, China Med Device, LLC (10')
-CACLP 2025 Introduction, Tiki Wang, Marketing Specialist of CACLP(10')
-Q&A (10')
Jade Sims, Commercial Officer
Jade Sims arrived in Beijing, China to begin her first tour as a Commercial Officer in August of 2022.
Her portfolio covers several industries, including advising the China Healthcare team. Prior to her work with U.S. Commercial Service, Ms. Sims was Assistant Director of International Trade Programs at Michigan State University’s International Business Center, where she provided trade counseling, training, and market research to U.S. exporters. She also taught international business and developed and led study abroad and internship programs on four continents.
Prior to her work at MSU, Ms. Sims worked in the automotive industry and served as a small business development volunteer with the Peace Corps. She holds an MBA Thunderbird School of Global Management and a BS in Business and Spanish from Alma College.
Karen Dai
General Manager, CACLP
Karen Dai is the Executive General Secretary of China Association of In-Vitro Diagnostics (www.caivd-org.cn) and the General Manager of CACLP (www.caclp.com).
Ms Dai has more than 20 years’ experience in trade fair industry and has successfully launched some key international shows in China in different industries. After joining in CAIVD and CACLP in 2020, she has been dedicated to developing the international network for global IVD companies together with the team. The mission of CAIVD and CACLP is to introduce the China market to overseas companies, and help Chinese companies connect with the global market!